N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butanamine and use thereof as a cardiotonic agent
US4517310A · kind A · utility
0Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 1981 |
| Grant date | May 14, 1985 |
| Priority date | — |
| Expiry date | Jul 28, 2001 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D235/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The compound N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butanamine and methods for its manufacture and use are described herein. The compound is a cardiotonic agent useful primarily in the treatment of congestive heart failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.